Trade
Group Sites
Premia
Business Partners
Wealth
FLAME
Property Solutions
IIFL Finance
IIFL MF
IIFL Associates
About IIFl
Contact IIFl
Investor Relations
We're HIRING
FEEDBACK
Register
Login
Sensex
19,704.33
+30.00
0.15%
Nifty
5,983.55
+16.50
0.28%
Commodity Ideas
Stock Ideas
IIFL Live
Customer Service
Corporate News
IIFL
Quote
News
Quotes
View all
MF
View all
Insurance
View all
Commodity
View all
No Result found
Home
Markets
Equities
Market Statistics
Charts
Market Map
Derivatives
Commodity
IPO
Companies
News
Overview
Top
Business
Corporate
Equities
Commodity
Currency
MF
Insurance
IPO
Economy
Global
M&A
Gold
PR Newswire
Dow Jones
Business Wire
Research & Ideas
Overview
Recommendations
Sectors
Market Analysis
Leader Speak
Featured Reports
Sector Indices
Articles
In Focus
Calendar
Economy
Mutual Funds
Fund Snapshot
Fund Houses
Equity Funds
Debt Funds
Balanced Funds
ETFs
NFO Updates
Dividend Tracker
Fund Manager Speak
Apply Online
Discuss
Discussions
Polls
Videos
Chat With Experts
Live TV
Personal Finance
Overview
Insurance
NRI Corner
Loans
Calculators
Articles
Union Budget
Railway Budget
Data Monitor
Blog
Portfolio
Company Snapshot
Research
India Infoline Research
MF Investments
FII Investments
Bulk Deals
Block Deals
Daily Share Prices
Monthly Share Prices
Fundamentals
Profit & Loss
Balance Sheet
Cash Flow
Key Ratios
Management
Discussions
Share Holding Pattern
Equity Capital
Structure
Director's Report
Auditor's Report
Quarterly Results
Half Yearly Results
Nine Monthly Results
Annual Results
Background
Key Executives
Board of Directors
Meeting Schedule
Stock history
Company Profile
Products & Services
Raw Materials
Finished Goods
Bankers
Auditors
Location
News
Company News
Sector News
Corporate
Announcements
IndiaInfoline
Markets
Companies
Glenmark Pharmaceuticals Ltd
BSE: 532296 | NSE: GLENMARK | ISIN: INE935A01035
Market Cap: [Rs.Cr.] 14,932 | Face Value: [Rs.] 1
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Discuss this stock
Bonus
Date
Ratio
04-Mar-05
1:1
Split
Date
FV Before
FV After
10-Sep-07
2.00
1.00
23-Oct-03
10.00
2.00
Rights
Date
Ratio
Premium
No Rights Found
Dividend
Year End
Dividend Per Share
Dividend(%)
Remark
19-Jul-12
2.0
200.0
Final
28-Jul-11
0.4
40.0
Final
16-Sep-10
0.4
40.0
Final
10-Sep-09
0.4
40.0
Final
07-Nov-07
1.4
70.0
Interim
04-Jan-07
0.8
40.0
Interim
27-Apr-05
0.0
35.0
Interim
India Infoline Research
Company
|
Sectors
Glenmark Pharmaceuticals (Q4 FY13)
Glenmark Pharmaceuticals (Q3 FY13)
Glenmark Pharmaceuticals (Q2 FY13)
Glenmark Pharma (Q1 FY13)
Glenmark Pharma (Q4 FY12)
Related News
Company
|
Sector
|
Latest
17-May-13
Glenmark Pharma drops after 3-day 8.2% rally
16-May-13
Glenmark Pharma hits 52-week high
15-May-13
Glenmark Generics receives final ANDA approvals for Zolmitriptan Tablets
15-May-13
Glenmark Pharma scales 52-week high
10-May-13
Glenmark Pharmaceuticals Appoints Company Secretary & Compliance Officer
09-May-13
Add Glenmark Pharma, tgt raised to Rs. 597/sh: IIFL Inst Eq
More News
Peer Comparison
Company
Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Sun Pharma.Inds.
100,416.95
69.76
12.38
27.45
26.1
27.0
0.01
Dr Reddy's Labs
35,071.23
27.71
4.61
18.79
14.3
16.6
0.25
Cipla
32,778.39
21.41
4.35
14.11
15.9
19.8
0.03
Ranbaxy Labs.
16,513.59
0.00
8.60
72.87
0.0
0.0
2.38
Cadila Health.
16,249.19
39.39
6.37
18.45
28.4
24.2
0.40
Glenmark Pharma.
14,932.01
38.68
5.92
23.94
12.7
11.7
0.39
Wockhardt
13,475.05
80.27
111.99
12.82
237.0
30.3
2.09
Piramal Enterp.
9,623.98
0.00
0.91
23.66
0.8
2.1
0.07
Ipca Labs.
7,202.23
21.66
5.71
10.09
24.2
23.7
0.49
Torrent Pharma.
6,125.22
11.46
4.70
11.66
29.6
25.5
0.48
Biocon
5,488.00
19.14
2.49
12.20
12.6
13.6
0.08
Strides Arcolab
5,270.21
35.93
3.84
46.94
7.3
8.9
0.56
Aurobindo Pharma
4,995.54
11.88
2.00
22.89
10.7
8.8
1.01
Mylan Lab.
3,273.19
6.80
1.77
0.00
26.9
26.1
0.59
Alembic Pharma
2,222.42
14.12
4.83
5.60
39.5
27.7
1.07
Prev
Next
Futures & Options Quote
Future
|
Option
Expiry Date
Stock not available in F&O
NA
Instrument:
NA
Expiry Date:
NA
Strike Price:
NA
Open Price:
NA
Average Price:
NA
No. of Contracts Traded:
NA
Open Interest:
NA
Underlying:
NA
Option Type:
NA
Market Lot:
NA
Previous Close:
NA
Day’s High | Low:
NA | NA
Turnover (Cr.):
NA
Open Int. Change:
NA | NA
View detailed F& O quotes >>
Key Information
Key Executives:
Glenn Saldanha , Chairman and MD & CEO
Julio F Ribeiro , Director
Natvarlal B Desai , Director
Sridhar Gorthi , Director
Company Head Office / Quarters:
B/2 Mahalaxmi Chambers,
22 Bhulabhai Desai Road,
Mumbai,
Maharashtra-400026
Phone : 91-22-40189999/879/56549999
Fax : 91-22-40189986/23512177/23519652
E-mail :
complianceofficer@glenmarkpharma.com
Web :
http://www.glenmarkpharma.com
Registrars:
Karvy Computershare Pvt Ltd
Plot No 17-24
Vittal Rao Nagar
Madhapur
Hyderabad-500081
Fund Holding
Mutual Funds
|
Fll
Scheme Name
No. of Shares
Morgan Stanley Growth Fund (G)
1,561,348
DSP BR Equity Fund (D)
1,244,385
HDFC Top 200 Fund (G)
950,000
Detailed List
Calendar
May-2013
M
T
W
T
F
S
S
20
21
22
23
24
25
26
IPO
Issue Open :
India Finsec
View full month IPO calendar
Economic Events
No economic event today
View full month Economic Events calendar
Results
Bharat Forge | Oil India | Container Corpn.
View full month Results calendar